Skip to main content

Spirometer Market Size to Surpass USD 891.5 Million by 2030, exhibiting a CAGR of 5.5%

As per the report by Fortune Business Insights, the global spirometer market size is projected to reach USD 891.5 million in 2030, at a CAGR of 5.5% during the forecast period, 2023-2030

Spirometer Market

Spirometer Market Forecast (2030-2030)
Spirometer Market Forecast (2030-2030)

Pune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) — The global spirometer market size is expected to expand from USD 613.3 million in 2023 to USD 891.5 million by 2030, exhibiting a CAGR of 5.5% over the study period. A spirometer is deployed for the diagnosis of chronic obstructive pulmonary disease (COPD), asthma, and other conditions that impact breathing.

Fortune Business Insights™ provides this information in its research report, titled “Spirometer Market, 2023-2030”.


Request a Free Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/spirometers-market-100486


Key Industry Development:

October 2022: NuvoAir announced a partnership with ArtiQ to allow automated quality control of spirometry data in clinical trials.


Key Takeaways:

  • Increased test volume measurement and demand for devices, market is anticipated to grow steadily during the forecast period.
  • The increasing prevalence of the disorder is an alarming situation worldwide that is expected to propel the demand for diagnostic devices.
  • The market expansion can be credited to the growing technological innovations in diagnostic tools.
  • The segment is expected to grow at a significant CAGR during the forecast period.
  • The market size in North America stood at USD 293.0 million in 2022.


List of Key Players Mentioned in the Report:

ndd Medizintechnik AG (Switzerland), COSMED srl (Italy), MGC Diagnostics Corporation (U.S.), Morgan Scientific (U.S.), Chest M.I., Inc. (Japan), VYAIRE (U.S.), Ganshorn Medizin Electronic GmbH (Germany), Medical International Research (MIR) (Italy)


Report Scope & Segmentation

Report CoverageDetails
Forecast Period2023 to 2030
Forecast Period 2023 to 2030 CAGR5.5%
2030 Value ProjectionUSD 891.5 million
Base Year2022
Market Size in 2023USD 613.3 million
Historical Data2019-2021
No. of Pages139
Segments CoveredBy  Product Type, Type, Application, End-User, and Region


Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/spirometers-market-100486


Segmentation:

Surging Investments by Major Companies Fuelled the Devices Segment Growth

Based on product type, the market is categorized into software, devices, and accessories & consumables. The growing investments by start-ups and major in the development of devices for the effective management of respiratory disorders propelled the segment growth.

Ease of Handling of Volume Measurement to Foster Segment Growth

By type, the market is bifurcated into peak flow meters and volume measurement. The volume measurement segment accounted for the largest spirometer market share in 2022. The ease of handling of the device is driving the volume measurement segment growth.

Rising Incidence of Pulmonary Infection Impelled Chronic Obstructive Pulmonary Disorder Segment Growth

In terms of application, the market is segmented into asthma, chronic obstructive pulmonary disorder (COPD), and others. The segment dominated the market in 2022, owing to the growing prevalence of pulmonary infections.

Rise in Healthcare Spending to Foster Hospitals Segment Growth

By end user, the market is classified into diagnostic centers, homecare settings, hospitals, physician/primary care offices or clinics, and other facilities. The hospitals segment is expected to register the largest share during the forecast period. The uptake of advanced pulmonary function testing solutions due to the growing healthcare expenditure is driving the hospitals segment growth.

By region, the market is segmented into the Asia Pacific, Europe, Latin America, the Middle East & Africa, and North America.

By Product Type

  • Devices
  • Software
  • Accessories & Consumables

By Type

  • Volume Measurement
  • Peak Flow Meters

By Application

  • Chronic Obstructive Pulmonary Disorder (COPD)
  • Asthma
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Physician/Primary Care Offices or Clinics
  • Other Facilities


Quick Buy: https://www.fortunebusinessinsights.com/checkout-page/100486


Drivers and Restraints:

Increasing Investment Opportunities to Boost the Market Growth

One of the major factors propelling the spirometer market growth is surge in investment opportunities. The top companies are emphasizing investments in the development of advanced devices due to the rising demand for accurate devices for assessing lung function.

Despite such growth opportunities, the lack of skilled professionals may hamper product adoption, impeding the market growth.


Regional Insights:

North America Dominated Due to Growing Prevalence of COPD

North America spirometer market accounted for the largest share in 2022. The surging incidence of COPD is driving the regional expansion.

The Asia Pacific market for spirometer is expected to witness exponential growth during the forecast period due to growing heavy investments by companies, which is poised to increase the demand for advanced products.

Competitive Landscape:

Prominent Players Forge Partnerships to Reinforce their Market Position

The leading companies operating in the market are focusing on various competitive strategies to enhance their position. Joint ventures, mergers and acquisitions, and product innovations are a few of these strategies. Several companies are also emphasizing partnership strategies to retain their industry standing.


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/spirometers-market-100486


FAQs

How big is the Spirometer Market?

Spirometer Market size is USD 613.3 million in 2023 and projected to grow USD 891.5 million by 2030.

How fast is the Spirometer Market growing?

The Spirometer Market will exhibit a CAGR of 5.5% during the forecast period, 2023-2030.


Related Links:

Pulmonary Function Testing System Market Size, Share, Growth Industry Report.

Respiratory Devices Market Share, Size, Demand, and Forecast.

Chronic Obstructive Pulmonary Disease Drugs Market Size, Share, Growth Industry Report.

Exam Room Equipment Market Share, Size, Demand, and Forecast.


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies interspersed with relevant data. 

Contact Us:

Fortune Business Insights Pvt. Ltd.

9th Floor, Icon Tower, Baner – Mahalunge Road,

Baner, Pune-411045,

Maharashtra, India.

Phone:
U.S.:+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.